Source: The Guardian. | From agreements of cross-border care to health research collaboration, public health protections and shared institutions; there is much at stake in this referendum debate. One key pillar of health is pharmaceuticals, where the London-based European Medicines Agency (EMA) has a central role in supporting medical innovation and ensuring patient protection. A Brexit would certainly mean losing the EMA to another EU country, but what would be the wider impacts for the UK pharmaceuticals industry and patient safety?.
Source: European Commission | FrailSafe will combine state of the art information technologies and data mining techniques with high-level expertise in the field of health and ageing. The project is funded by the European Research programme Horizon 2020 and will last three years.
This association EurHeCA (European Health Professionals’ Competent Authorities) has been created in 2011 and consists of European health professionals’ competent authorities.